A perspective on the use of minocycline for rheumatoid arthritis

Journal of Clinical Rheumatology

Volumn 5, Issue 4, 1999, Pages 233-238

  Cooper, Sheldon M ^a,b  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Minocycline; Rheumatoid arthritis; Tetracyclines

Indexed keywords

DOXYCYCLINE; INTERLEUKIN 1; MATRIX METALLOPROTEINASE; METHOTREXATE; MINOCYCLINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PLACEBO; TETRACYCLINE DERIVATIVE; TUMOR NECROSIS FACTOR;

APOPTOSIS; CARTILAGE CELL; CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; GASTROINTESTINAL TOXICITY; HUMAN; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SKIN TOXICITY; SYMPTOMATOLOGY; TREATMENT OUTCOME; VERTIGO;

EID: 0032816662     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124743-199908000-00011     Document Type: Review

References (28)

1. Brown TM, Bush SW, Felts WR. In: Wohl MG, editors. Long-term illness: management of the chronically ill patient. Philadelphia: W.B. Saunders. 1959. p. 93-125.
2. Golub LM, Lee HM, Lehrer G, Nemiroff A, McNamara TF, Kaplan R, et al. Minocycline reduces gingival collagenolytic activity during diabetes. Preliminary observations and a proposed new mechanism of action. J Periodontal Res 1983;18:516-24.
3. Greenwald RA. Tetracyclines may be therapeutically beneficial in rheumatoid arthritis, but not for the reasons that you might think. J Clin Rheumatol 1995;1:185-9.
4. Alarcón, GS. Tetracyclines in the treatment of rheumatoid arthritis: they work, but we do not know the reason(s). J Clin Rheumatol 1995;1:190-3.
5. Breedveld FC, Dijkmans BAC, Mattie H. Minocycline treatment for rheumatoid arthritis: an open dose finding study. J Rheumatol 1990;17: 43-6.
6. Langevitz P, Zemer D, Book M, Pras M. Treatment of resistant rheumatoid arthritis with minocycline: an open study. J Rheumatol 1992;19:1502-4.
7. Kloppenburg M, Breedveld FC, Terwiel JP, Mallee C, Dijkmans BAC. Minocycline in active rheumatoid arthritis. Arthritis Rheum 1994;37:629-36.
8. Tilley BC, Alarcón GS, Heyse SP, Trentham DE, Neuner R, Kaplan DA, et al. for the MIRA Trial Group. Minocycline in rheumatoid arthritis: a 48-week, double-blind, placebo-controlled trial. Ann Intern Med 1995; 122:81-9.
9. O'Dell JR, Haire CE, Palmer W, Drymalski W, Wees S, Blakely K, et al. Treatment of early rheumatoid arthritis with minocycline or placebo: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum 1997; 40:842-8.
10. Pillemer SR, Fowler SE, Tilley BC, Alarcón GS, Heyse SP, Trentham DE, et al. for the MIRA Trial Group. Meaningful improvement criteria sets in a rheumatoid arthritis clinical trial. Arthritis Rheum 1997;40:419-25.
11. Bluhm GB, Sharp JT, Tilley BC, Alarcón GS, Cooper SM, Pillemer SR, et al. Radiographic results from the minocycline in rheumatoid arthritis (MIRA) trial. J Rheumatol 1997;24: 1295-302.
12. O'Dell JR, Haire C, Palmer W, Churchill M, Blakely K, Eckhoff J, et al. Minocycline therapy for early rheumatoid arthritis: continued efficacy at three years. Arthritis Rheum 1997; 40:S219.
13. Greenwald RA, Golub LM, Lavietes B, Ramamurthy NS, Gruber B, Laskin RS, et al. Tetracyclines inhibit human synovial collagenase in vivo and in vitro. J Rheumatol 1987; 14:28-32.
14. Yu LP Jr, Smith GN Jr, Brandt KD, Myers SL, O'Connor BL, Brandt DA. Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycycline. Arthritis Rheum 1992;35:1150-9.
15. Yu LP Jr, Smith GN Jr, Hasty KA, Brandt KD. Doxycycline inhibits type XI collagenolytic activity of extracts from human osteoarthritic cartilage and of gelatinase. Arthritis Rheum 1991;18:1450-2.
16. Palmer RMJ, Hickery MS, Charles IG, Moncada S, Bayliss MT. Induction of nitric oxide synthase in human chondrocytes. Biochem Biophys Res Commun 1993;193:398-405.
17. Amin AR, Di Cesare PE, Vyas P, Attur M, Tzeng E, Billiar TR, et al. The expression and regulation of nitric oxide synthase in human osteoarthritis-affected chondrocytes: evidence for up-regulated neuronal nitric oxide synthase. J Exp Med 1995;182:2097-102.
18. McInnes IB, Leung BP, Field M, Wei XQ, Huang FP, Sturrock RD, et al. Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J Exp Med 1996;184:1519-24.
19. Farrell AJ, Blake D, Palmer RMJ, Moncada S. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann Rheum Dis 1992;51:1219-22.
20. Taskiran D, Stefanovic-Racic M, Georgescu H, Evans C. Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin-1. Biochem Biophys Res Comm 1994;200: 142-8.
21. Murrell GA, Jang D, Williams RJ. Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem Biophys Res Commun 1995;206:15-21.
22. Blanco FJ, Ochs RL, Schwarz H, Lotz M. Chondrocyte apoptosis induced by nitric oxide. Am J Pathol 1993;146:75-85.
23. Hashimoto S, Takahasi K, Amiel D, Coutts RD, Lotz M. Chondrocyte apoptosis and nitric oxide production during experimentally induced osteoarthritis. Arthritis Rheum 1998;41: 1266-74.
24. Blanco FJ, Guitian R, Vázquez-Martul E, de Toro FJ, Galdo F. Osteoarthritis chondrocytes die by apoptosis. A possible pathway for osteoarthritis pathology. Arthritis Rheum 1998;41:284-9.
25. Amin AR, Attur MG, Thakker GD, Patel PD, Vyas PR, Patel RN, et al. A novel mechanism of action of tetracyclines: effects on nitric oxide synthases. Proc Natl Acad Sci USA 1996; 93:14014-19.
26. Gough A, Chapman S, Wagstaff K, Emery P, Elias E. Minocycline induced auto-immune hepatitis and an SLE-like syndrome. BMJ 1996;312:169-72.
27. Angulo JM, Sigal LH, Espinoza, LR. Coexistent minocycline-induced systemic lupus erythematosus and autoimmune hepatitis. Semin Arthritis Rheum 1998;28:187-92.
28. Reveille JD, Alarcón GS, Flowler SE, Pillemer SR, Neuner R, Clegg DO, et al. HLA-DRB1 genes and disease severity in rheumatoid arthritis. Arthritis Rheum 1996:39:1802-7.